A Conversation with FDA's Janet Woodcock

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Center for Drug Evaluation & Research Director Janet Woodcock discusses her new role as interim director in the Office of New Drugs (OND) following the departure of John Jenkins, an update on the Office of Pharmaceutical Quality (OPQ), accelerating new drug approvals, and orphan drug development.

Visit the podcast's native language site